The diagnostic accuracy of 18F-Fluorodeoxyglucose PET/CT in patients with gynecological malignancies

被引:56
|
作者
Grisaru, D
Almog, B
Levine, C
Metser, U
Fishman, A
Lerman, H
Lessing, JB
Even-Sapir, E
机构
[1] Tel Aviv Sourasky Med Ctr, Dept Obstet & Gynecol, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Dept Radiol, IL-64239 Tel Aviv, Israel
[3] Tel Aviv Sourasky Med Ctr, Dept Nucl Med, IL-64239 Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Meir Med Ctr, Dept Obstet & Gynecol, IL-69978 Tel Aviv, Israel
关键词
positron emission tomography/computerized tomography; staging; follow-up;
D O I
10.1016/j.ygyno.2004.05.053
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To evaluate the diagnostic accuracy of integrated positron emission tomography/computerized tomography (PET/CT) in patients with gynecological cancer. Methods. Fifty-three consecutive patients with gynecologic malignancies were included. The patients were referred to our tertiary center to undergo a PET/CT scan. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT were compared with the conventional imaging assessments [CT, magnetic resonance imaging (MRI) and ultrasonography (US)]. Results. All tested values were higher for PET/CT than those for the conventional modalities: sensitivity 0.97 vs. 0.40, specificity 0.94 vs. 0.65, PPV 0.97 vs. 0.70, and NPV 0.94 vs. 0.34, respectively. Conclusion. PET/CT is a reliable modality for assessing the extent of disease in patients with gynecologic malignancy. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:680 / 684
页数:5
相关论文
共 50 条
  • [21] Diagnostic performance of 18F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with 18F-fluorodeoxyglucose PET/CT
    Masatoyo Nakajo
    Masayuki Nakajo
    Yoriko Kajiya
    Megumi Jinguji
    Nobuaki Nishimata
    Shunji Shimaoka
    Tohru Nihara
    Kuniaki Aridome
    Sadao Tanaka
    Yoshihiko Fukukura
    Atushi Tani
    Chihaya Koriyama
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1223 - 1232
  • [22] Diagnostic performance of 18F-fluorothymidine PET/CT for primary gastric cancer and its lymph node metastasis: Comparison with 18F-fluorodeoxyglucose PET/CT
    Nakajo, M.
    Kajiya, Y.
    Tani, A.
    Jinguji, M.
    Nakabeppu, Y.
    Nakajo, M.
    Shimaoka, S.
    Nihara, T.
    Tanaka, S.
    Yoshiura, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S24 - S24
  • [23] Diagnostic performance of 18F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with 18F-fluorodeoxyglucose PET/CT
    Nakajo, Masatoyo
    Nakajo, Masayuki
    Kajiya, Yoriko
    Jinguji, Megumi
    Nishimata, Nobuaki
    Shimaoka, Shunji
    Nihara, Tohru
    Aridome, Kuniaki
    Tanaka, Sadao
    Fukukura, Yoshihiko
    Tani, Atushi
    Koriyama, Chihaya
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (08) : 1223 - 1232
  • [24] Evaluation of cytokines in diffuse splenic 18F-Fluorodeoxyglucose uptake of PET CT
    Kim, Keunyoung
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [25] 18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations
    Agarwal, Krishan Kant
    Seth, Rachna
    Behra, Abhishek
    Jana, Manisha
    Kumar, Rakesh
    JAPANESE JOURNAL OF RADIOLOGY, 2016, 34 (04) : 267 - 276
  • [26] 18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations
    Krishan Kant Agarwal
    Rachna Seth
    Abhishek Behra
    Manisha Jana
    Rakesh Kumar
    Japanese Journal of Radiology, 2016, 34 : 267 - 276
  • [27] Methods for preparing and acquiring PET/CT exams with 18F-Fluorodeoxyglucose and 18F-Fluoromethycholine
    Sanco, R.
    Zappala, M.
    Arnoldo, V.
    Memo, L.
    Zaramella, E.
    Carraro, A.
    Evangelista, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S167 - S167
  • [28] The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies
    Tian, JH
    Chen, L
    Wei, B
    Shao, MZ
    Ding, Y
    Yin, DY
    Yao, SL
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (08) : 825 - 831
  • [29] The impact of 18F-Fluorodeoxyglucose (FDG) PET/CT in the management of patients with pyrexia of unknown origin (PUO)
    Harris, P.
    Newport, M.
    Llewelyn, M.
    Peters, A. M.
    Dizdarevic, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S603 - S603
  • [30] 18F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer A cytopathological correlation
    Letovanec, I.
    Allenbach, G.
    Mihaescu, A.
    Lalonde, M. Nicod
    Schmidt, S.
    Stupp, R.
    Fitting, J. -W.
    Boubaker, A.
    Ris, H. -B.
    Prior, J. O.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2012, 51 (05): : 186 - 193